pneumonia
infect
lower
airway
distal
bronchi
alveoli
caus
virus
bacteria
communityacquir
pneumonia
cap
specif
refer
clinic
sign
symptom
pneumonia
acquir
outsid
hospit
set
one
common
seriou
infect
childhood
account
death
among
children
younger
year
age
although
rate
mortal
due
cap
much
lower
develop
world
compar
develop
world
cap
continu
account
signific
proport
health
care
visit
hospit
highincom
countri
review
focus
pediatr
cap
unit
state
industri
nation
specif
highlight
chang
epidemiolog
cap
diagnost
therapeut
challeng
area
research
unit
state
cap
account
approxim
million
outpati
visit
annual
among
common
caus
hospit
approxim
pediatr
hospit
annual
annual
incid
hospit
per
children
highest
rate
health
care
util
occur
children
younger
year
age
decreas
increas
age
pediatr
popul
children
pneumonia
often
present
fever
tachypnea
sign
respiratori
distress
tabl
sign
symptom
may
includ
tachypnea
cough
dyspnea
retract
grunt
hypoxemia
abdomin
pain
lethargi
physic
examin
find
decreas
breath
sound
crackl
rale
wheez
auscult
lung
field
mani
find
overlap
acut
lower
respiratori
tract
diseas
eg
asthma
viral
bronchiol
identifi
children
pneumonia
base
clinic
sign
symptom
sometim
difficult
result
chest
radiograph
commonli
use
confirm
diagnosi
even
chest
radiograph
reveal
infiltr
howev
sometim
difficult
differenti
consolid
repres
pneumonia
atelectasi
commonli
seen
children
asthma
bronchiol
result
variat
chest
radiograph
interpret
common
may
contribut
antibiot
overus
reason
guidelin
develop
pediatr
infecti
diseas
societi
pid
infecti
diseas
societi
america
idsa
discourag
use
chest
radiograph
children
suspect
uncompl
pneumonia
outpati
set
chest
radiograph
recommend
children
hospit
hypoxemia
respiratori
distress
suspect
complic
parapneumon
effus
necrot
pneumonia
pneumothorax
fig
chest
ultrasound
often
use
evalu
local
complic
parapneumon
effus
empyema
recent
studi
demonstr
high
sensit
specif
detect
lung
consolid
compar
chest
radiographi
addit
benefit
chest
ultrasound
includ
lack
ioniz
radiat
avail
emerg
depart
set
import
limit
ultrasound
evalu
interpret
highli
oper
depend
thu
despit
promis
earli
studi
largescal
pragmat
studi
need
better
evalu
effect
imag
techniqu
versu
standard
chest
radiographi
pneumonia
heterogen
diseas
caus
varieti
pathogen
includ
virus
bacteria
histor
cap
larg
consid
bacteri
process
often
due
streptococcu
pneumonia
haemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
introduct
routin
childhood
vaccin
streptococcu
pneumonia
h
influenza
howev
dramat
reduc
diseas
caus
pathogen
time
highli
sensit
molecular
diagnost
viral
respiratori
pathogen
heighten
awar
impact
virus
caus
cap
studi
michelow
colleagu
exemplifi
prepneumococc
conjug
vaccin
pcv
era
etiolog
studi
studi
use
tradit
cultur
method
pneumolysinbas
polymeras
chain
reaction
pcr
assay
viral
direct
fluoresc
antibodi
test
serolog
test
virus
mycoplasma
spp
chlamydia
spp
identifi
pathogen
hospit
children
radiograph
confirm
lower
respiratori
infect
singl
institut
major
patient
note
infect
typic
respiratori
bacteria
commonli
streptococcu
pneumonia
detect
children
document
bacteri
diseas
virus
identifi
children
pcv
target
common
clinic
import
pneumococc
serotyp
introduc
unit
state
childhood
immun
schedul
rate
invas
pneumococc
diseas
caus
serotyp
children
less
year
age
plummet
averag
case
case
per
popul
within
year
introduct
hospit
rate
cap
pneumoniaassoci
complic
among
young
children
decreas
respect
despit
declin
diseas
caus
nonvaccin
serotyp
soon
emerg
rate
complic
pneumonia
increas
prompt
introduct
expand
pct
us
childhood
immun
program
sinc
time
hospit
rate
decreas
per
admiss
era
per
admiss
era
rate
complic
pneumococc
pneumonia
decreas
significantli
pneumonia
etiolog
postpneumococc
conjug
vaccin
era
multicent
center
diseas
control
prevent
cdc
etiolog
pneumonia
commun
epic
studi
prospect
populationbas
surveil
studi
greater
pediatr
cap
hospit
unit
state
conduct
studi
use
serolog
nasopharyng
pcr
identifi
differ
virus
culturebas
method
wholeblood
pcr
pneumococc
lyta
identifi
typic
bacteria
nasopharyng
pcr
identifi
atyp
bacteri
pathogen
virus
identifi
greater
children
wherea
bacteria
identifi
children
fig
common
viral
pathogen
includ
respiratori
syncyti
viru
rsv
human
rhinoviru
human
metapneumoviru
adenoviru
detect
greater
children
rsv
adenoviru
human
metapneumoviru
commonli
identifi
children
younger
year
age
compar
older
children
bacteria
identifi
approxim
children
cdc
epic
studi
although
streptococcu
pneumonia
identifi
children
underscor
impact
pcv
epidemiolog
pediatr
cap
mycoplasma
pneumonia
frequent
identifi
bacteri
pathogen
detect
children
includ
schoolag
children
children
younger
year
age
bacteria
identifi
less
children
importantli
children
cdc
epic
studi
pathogen
identifi
highlight
continu
need
enhanc
diagnost
novel
pathogen
discoveri
techniqu
pathogen
less
commonli
seen
among
us
children
includ
mycobacterium
tuberculosi
fungi
burkholderia
cepacia
aspergillu
fumigatu
pseudomona
aeruginosa
usual
occur
patient
underli
risk
factor
immunocompromis
condit
chronic
condit
cystic
fibrosi
spinal
muscular
atrophi
histori
intern
travel
tabl
pathogen
also
suspect
patient
experi
treatment
failur
common
etiolog
agent
pidsidsa
cap
guidelin
recommend
obtain
blood
cultur
children
hospit
cap
set
howev
blood
cultur
identifi
pathogen
children
cap
blood
cultur
often
posit
children
parapneumon
effus
rang
outpati
set
blood
cultur
routin
recommend
posit
rate
low
result
unlik
chang
manag
regardless
despit
group
b
streptococci
neonat
pneumonia
sepsi
neonat
pneumonia
sepsi
gramneg
enter
neonat
pneumonia
sepsi
potenti
pathogen
aspir
pneumonia
caus
afebril
pneumonia
young
infant
mo
age
anaerob
oral
flora
potenti
pathogen
aspir
pneumonia
legionnair
diseas
rare
children
associ
commun
outbreak
exposur
contamin
artifici
freshwat
system
coxiella
burnetti
q
fever
exposur
wild
domest
herbivor
unpasteur
dairi
eg
cattl
sheep
goat
also
potenti
bioterror
agent
psittacosi
bird
eg
pet
bird
pigeon
exposur
tularemia
rabbit
exposur
yersinia
pesti
pneummon
plagu
rodent
flea
exposur
anthrax
woolsort
diseas
wild
domest
herbivor
eg
cattl
sheep
goat
exposur
also
potenti
bioterror
agent
leptospirosi
exposur
urin
wild
domest
anim
carri
bacterium
rare
us
children
usual
associ
highrisk
exposur
brucellosi
exposur
wild
domest
anim
unpasteur
dairi
eg
cattl
sheep
pig
goat
deer
dog
histoplasmosi
exposur
bird
bat
drop
eg
poultri
bird
roost
cave
endem
eastern
central
unit
state
blastomycosi
environment
exposur
fungal
spore
wood
area
endem
southeastern
midwestern
unit
state
cryptococcosi
exposur
soil
contamin
bird
drop
signific
pathogen
nearli
exclus
among
immunocompromis
low
yield
blood
cultur
current
provid
best
opportun
identifi
typic
bacteri
pathogen
children
cap
diagnost
yield
blood
cultur
optim
restrict
use
patient
increas
pretest
probabl
posit
cultur
sever
ill
parapneumon
effus
isol
patholog
organ
occur
significantli
less
frequent
patient
expos
antibiot
specimen
collect
studi
also
demonstr
increas
yield
blood
cultur
addit
millilit
blood
drawn
obtain
adequ
weightbas
blood
volum
also
associ
lower
rate
blood
cultur
contamin
reason
yet
unknown
contamin
rate
also
minim
adher
proper
steril
collect
method
cultur
lower
respiratori
tract
pleural
fluid
cultur
posit
case
perform
whenev
pleural
fluid
obtain
invas
method
associ
sampl
pleural
space
howev
make
impract
obtain
pleural
fluid
specimen
except
dictat
clinic
care
bronchoalveolar
lavag
rare
indic
cap
except
instanc
lack
respons
therapi
sever
pneumonia
immunocompromis
host
opportunist
pathogen
suspect
sputum
cultur
low
diagnost
yield
children
due
inabl
young
children
pneumonia
produc
adequ
sputum
sampl
pretreat
antibiot
hinder
diagnost
yield
induc
sputum
explor
opportun
collect
sputum
sampl
young
children
although
util
limit
frequent
detect
upper
respiratori
tract
bacteria
similar
rate
recoveri
pathogen
pneumonia
case
compar
children
without
pneumonia
molecular
diagnost
pneumococc
urinari
antigen
test
often
use
evalu
pneumonia
adult
children
howev
detect
streptococcu
pneumonia
urinari
antigen
associ
falseposit
result
due
high
rate
nasopharyng
colon
recent
serotypespecif
urinari
antigen
detect
method
develop
valid
adult
pneumonia
whether
test
could
prove
use
children
remain
determin
although
wide
use
clinic
set
wholeblood
pneumococc
pcr
lyta
use
epidemiolog
studi
includ
epic
pneumonia
etiolog
research
child
health
perch
potenti
benefit
includ
improv
sensit
rapid
turnaround
time
less
influenc
antibiot
pretreat
compar
culturebas
method
epic
studi
children
test
pcrposit
streptococcu
pneumonia
wherea
blood
cultur
posit
pneumococcu
children
p
perch
studi
children
pneumonia
pneumococc
pcrposit
wherea
children
denomin
provid
posit
blood
cultur
streptococcu
pneumonia
moreov
although
prior
studi
demonstr
specif
lyta
pneumococc
pcr
blood
perch
studi
also
identifi
pneumococc
dna
blood
control
children
thu
although
pneumococc
pcr
may
increas
rate
detect
blood
cultur
suboptim
test
specif
hamper
interpret
pcr
also
increas
yield
pleural
fluid
specimen
studi
evalu
archiv
pleural
fluid
specimen
pediatr
patient
cap
pathogen
detect
sampl
use
pcr
compar
sampl
use
convent
cultur
method
p
frequent
pathogen
detect
use
pediatr
communityacquir
pneumonia
method
streptococcu
pneumonia
use
pcr
use
convent
cultur
next
frequent
pathogen
identifi
streptococcu
pyogen
use
pcr
use
convent
cultur
aureu
use
pcr
use
convent
cultur
studi
also
highlight
potenti
bia
respect
pathogen
identif
introduc
reli
cultur
alon
epidemiolog
studi
penicillinresist
pneumococc
isol
aureu
like
posit
cultur
wherea
serotyp
streptococcu
pneumonia
bacteri
pathogen
commonli
suscept
penicillin
commonli
identifi
pcr
twothird
children
younger
year
colon
upper
respiratori
tract
common
bacteri
pathogen
known
caus
pneumonia
pcr
upper
respiratori
tract
reliabl
method
ascertain
bacteri
etiolog
pneumonia
possibl
except
pneumonia
previous
consid
frequent
colon
upper
respiratori
tract
consist
theori
cdc
epic
studi
demonstr
although
pneumonia
detect
children
pneumonia
fewer
control
evid
pneumonia
contrast
crosssect
observ
studi
netherland
asymptomat
children
children
symptom
upper
lower
respiratori
tract
infect
detect
pneumonia
dna
symptomat
children
also
asymptomat
children
given
conflict
result
studi
increas
commerci
avail
pneumonia
pcr
test
caution
warrant
interpret
test
result
clinic
set
contrast
bacteria
pcr
test
virus
upper
respiratori
sampl
larg
replac
cultur
serologybas
method
investig
pneumonia
etiolog
owe
superior
sensit
rapid
turnaround
time
abil
identifi
virus
difficult
grow
cultur
major
concern
howev
whether
lower
respiratori
tract
diseas
attribut
viral
pathogen
detect
upper
airway
scope
problem
well
illustr
studi
conduct
self
colleagu
compar
pcr
detect
virus
upper
respiratori
tract
among
children
cap
healthi
asymptomat
children
enrol
cdc
epic
studi
overal
approxim
asymptomat
children
virus
detect
compar
approxim
children
cap
detect
virus
higher
among
children
cap
compar
asymptomat
control
includ
influenza
vs
rsv
vs
human
metapneumoviru
vs
attribut
fraction
greater
convers
rhinoviru
detect
similar
frequenc
children
cap
asymptomat
children
vs
attribut
fraction
ci
attribut
fraction
virus
studi
rang
thu
although
virus
detect
upper
airway
like
reflect
lower
airway
diseas
eg
rsv
influenza
human
metapneumoviru
detect
virus
must
interpret
caution
propos
adult
investig
viral
load
may
help
differenti
diseas
versu
asymptomat
colon
sensit
method
diagnos
viral
infect
becom
wide
avail
recognit
viral
bacteri
coinfect
also
increas
well
known
upper
tract
diseas
respiratori
virus
often
preced
develop
bacteri
pneumonia
although
alway
clear
viru
detect
upper
airway
repres
prior
concurr
infect
subject
bacteri
pneumonia
studi
suggest
viralbacteri
codetect
associ
sever
clinic
cours
compar
singl
viral
bacteri
detect
associ
influenza
coinfect
pneumococc
staphylococc
pneumonia
perhap
best
describ
viral
bacteri
coinfect
elev
leukocyt
count
tradit
consid
associ
seriou
bacteri
infect
specif
leukocyt
count
make
diagnosi
bacteri
pneumonia
children
poor
degre
elev
reliabl
distinguish
viral
bacteri
pneumonia
routin
measur
leukocyt
count
like
benefici
recent
biomark
use
detect
pneumonia
includ
creactiv
protein
crp
procalcitonin
pct
biomark
may
perform
better
leukocyt
count
identifi
bacteri
infect
although
identifi
relev
clinic
cutpoint
remain
challeng
evalu
impact
crp
etiolog
diagnosi
pneumonia
metaanalysi
studi
children
viral
bacteri
caus
cap
demonstr
crp
level
greater
equal
mgl
mgl
associ
posit
predict
valu
identifi
children
bacteri
pneumonia
pct
peptid
precursor
calcitonin
produc
c
cell
thyroid
gland
neuroendocrin
cell
lung
intestin
level
usual
undetect
healthi
individu
increas
respons
system
inflamm
cytokin
typic
associ
bacteri
infect
enhanc
pct
releas
wherea
interferon
often
associ
viral
infect
inhibit
pct
releas
thu
much
interest
direct
pct
potenti
biomark
bacteri
diseas
among
hospit
children
enrol
cdc
epic
studi
pct
cutoff
valu
ngml
demonstr
sensit
specif
cap
caus
typic
bacteri
pathogen
studi
also
found
higher
pct
level
associ
sever
diseas
multipl
studi
shown
util
use
pct
level
guid
antibiot
initi
durat
biomark
studi
use
transcriptom
show
promis
enhanc
diagnost
capabl
use
host
respons
identifi
possibl
pathogen
studi
diseas
sever
transcriptom
use
gene
express
profil
measur
activ
express
thousand
gene
therebi
creat
global
pictur
cellular
activ
profil
peripher
blood
leukocyt
patient
lower
respiratori
tract
infect
accur
distinguish
influenza
viral
infect
bacteri
infect
predict
diseas
sever
host
transcript
profil
also
shown
use
distinguish
symptomat
rhinoviru
infect
incident
detect
children
promis
studi
like
add
much
understand
pneumonia
etiolog
outcom
although
much
work
remain
prior
translat
new
technolog
bedsid
sever
prognost
model
avail
adult
pneumonia
applic
shown
contribut
improv
outcom
unfortun
analog
model
valid
children
recogn
key
knowledg
gap
recent
william
colleagu
deriv
prognost
model
identifi
risk
sever
outcom
among
children
cap
model
demonstr
good
predict
accuraci
concord
index
studi
extrem
age
vital
sign
chest
indraw
radiograph
infiltr
pattern
rank
among
import
predictor
diseas
outcom
although
model
requir
valid
use
could
reduc
variabl
improv
care
children
pneumonia
although
virus
major
caus
childhood
pneumonia
major
children
pneumonia
receiv
antibiot
pneumonia
associ
antibiot
use
us
pediatr
hospit
condit
antibiot
indic
amoxicillin
ampicillin
recommend
firstlin
therapi
children
tabl
prior
releas
nation
guidelin
howev
broaderspectrum
thirdgener
cephalosporin
macrolid
commonli
use
date
impact
nation
guidelin
prescrib
mix
approxim
year
guidelin
public
penicillin
use
increas
approxim
cephalosporin
use
decreas
approxim
across
tertiari
care
children
hospit
unit
state
although
substanti
variabl
note
across
institut
similar
variabl
persist
outpati
set
antimicrobi
stewardship
program
local
clinic
practic
guidelin
qualiti
improv
method
play
import
role
rais
awar
recommend
reduc
unnecessari
inappropri
antibiot
use
current
practic
treatment
uncompl
cap
gener
use
antibiot
cours
although
larg
pediatr
random
control
studi
current
evalu
safeti
efficaci
shorter
cours
antibiot
unit
kingdom
communityacquir
pneumonia
studi
capit
us
phase
iv
doubleblind
placebocontrol
random
trial
short
cours
outpati
therapi
commun
acquir
pneumonia
scoutcap
consider
altern
etiolog
aureu
warrant
children
sever
rapidli
progress
diseas
extens
local
complic
poor
treatment
respons
aureu
uncommon
caus
cap
detect
children
hospit
pneumonia
thu
preserv
effect
antistaphylococc
antibiot
care
must
taken
consid
use
agent
empir
effort
deescal
therapi
whenev
possibl
emphas
although
pneumonia
frequent
caus
cap
children
imposs
reliabl
distinguish
pathogen
common
caus
pneumonia
question
regard
util
current
avail
pcr
test
pneumonia
outlin
previous
complic
treatment
consider
moreov
azithromycin
use
associ
develop
multidrug
resist
perhap
import
consider
govern
use
macrolid
therapi
howev
current
avail
studi
fail
consist
demonstr
benefit
children
pneumonia
despit
advanc
recent
year
cap
continu
caus
signific
morbid
mortal
pose
diagnost
therapeut
challeng
vaccin
haemophilu
influenza
type
b
streptococcu
pneumonia
greatli
reduc
invas
diseas
rate
caus
pathogen
introduct
molecular
diagnost
highlight
import
role
respiratori
virus
play
diseas
pathogenesi
also
introduc
new
challeng
updat
understand
bring
question
whether
children
cap
would
benefit
antibiot
therapi
therapi
might
effect
limit
current
diagnost
howev
imped
advanc
toward
address
import
question
biomark
host
respons
infect
current
area
intens
studi
may
facilit
deeper
understand
pneumonia
etiolog
diseas
outcom
import
work
progress
futur
epidemiolog
studi
use
stateoftheart
diagnost
continu
serv
import
role
inform
understand
chang
epidemiolog
cap
